advertisement
11.4 Prostaglandins (19)
Showing records 1 to 19
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins16969 Direct matrix metalloproteinase enhancement of transscleral permeability
Lindsey JD; Crowston JG; Tran A; Morris C; Weinreb RN
Investigative Ophthalmology and Visual Science 2007; 48: 752-755
16968 Dietary omega 3 fatty acids decrease intraocular pressure with age by increasing aqueous outflow
Nguyen CT; Bui BV; Sinclair AJ; Vingrys AJ
Investigative Ophthalmology and Visual Science 2007; 48: 756-762
16955 Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost
Tamer C; Oksuz H
Ophthalmic Research 2007; 9: 24-31
17082 Comparison of the effects of latanoprost and travoprost on intraocular pressure in chronic angle-closure glaucoma
Chen M-J; Chen Y-C; Chou C-K; Hsu W-M
Journal of Ocular Pharmacology and Therapeutics 2006; 22: 449-454
17175 Comparison of diurnal intraocular pressure control by latanoprost versus travoprost: Results of an observational survey
Denis P; Launois R; Devaux M; Berdeaux G
Clinical Drug Investigation 2006; 26: 703-714
16759 Meta-analysis of randomised controlled trials comparing latanoprost with brimonidine in the treatment of open-angle glaucoma, ocular hypertension or normal-tension glaucoma
Fung AT; Reid SE; Jones MP; Healey PR; McCluskey PJ; Craig JC
British Journal of Ophthalmology 2007; 91: 62-68
17051 Comparison of the stability, efficacy, and adverse effect profile of the innovator 0.005% latanoprost ophthalmic solution and a novel cyclodextrin-containing formulation
Gonzalez JR; Baiza-Duran L; Quintana-Hau J; Tornero-Montano R; Castaneda-Hernandez G; Ortiz M; Alarcon-Oceguera F; Beltran-Loustaunau M; Cortez-Gastelum M; Garciduenas-Mejia J
Journal of Clinical Pharmacology 2007; 47: 121-126
16837 Latanoprost versus timolol gel-forming solution once daily in primary open-angle glaucoma or ocular hypertension
Harasymowycz P; Hutnik CM; Nicolela M; Stewart WC
Canadian Journal of Ophthalmology 2007; 42: 75-81
17050 Relationship between travoprost and central corneal thickness in ocular hypertension and open-angle glaucoma
Harasymowycz PJ; Papamatheakis DG; Ennis M; Brady M; Gordon KD; Archambault P; Bazin G; Boucher S; Brochu J; Charbonneau A
Cornea 2007; 26: 34-41
17140 Prostanoids in the therapy of glaucoma
Ishida N; Odani-Kawabata N; Shimazaki A; Hara H
Cardiovascular Drug Reviews 2006; 24: 1-10
17086 An open-label multicenter study on the efficacy and safety of topical use of latanoprost for 156 weeks
Kitazawa Y
Japanese Journal of Clinical Ophthalmology 2006; 60: 2047-2054
16796 A 6-month assessment of bimatoprost 0.03% vs timolol maleate 0.5%: hypotensive efficacy, macular thickness and flare in ocular-hypertensive and glaucoma patients
Martin E; Martinez-de-la-Casa JM; Garcia-Feijoo J; Troyano J; Larrosa JM; Garcia-Sanchez J
Eye 2007; 21: 164-168
16884 Comparison of the ocular hypotensive effects of bimatoprost and timolol-dorzolamide combination in patients with elevated intraocular pressure: a 6-month study
Ozturk F; Ermis SS; Inan UU
Acta Ophthalmologica Scandinavica 2007; 85: 80-83
17139 Long-term effects of isopropyl unoprostone monotherapy on intraocular pressure and visual field for normal-tension glaucoma and primary open-angle glaucoma patients
Saito Y; Saeki T; Sugiyama K
Nippon Ganka Gakkai Zasshi 2006; 110: 717-722
16823 Midterm response with latanoprost therapy in german ocular hypertension patients
Thelen U; Christ T; Schnober D; Hofstetter HJ; Stewart WC
Current Eye Research 2007; 32: 51-56
16879 Effects of travoprost on aqueous humor dynamics in patients with elevated intraocular pressure
Toris CB; Zhan G; Fan S; Dickerson JE; Landry TA; Bergamini MVB; Camras CB
Journal of Glaucoma 2007; 16: 189-195
17173 Tafluprost. Prostanoid FP receptor agonist, antiglaucoma drug
Wang Y; Bolos J; Serradell N
Drugs of the Future 2006; 31: 788-792
17193 The present role of prostaglandin analogues in the medical treatment of glaucoma
Wierzbowska J; Rekas M; Malawko D
Klinika Oczna 2005; 107: 312-315
16897 Travoprost 0.004% with and without benzalkonium chloride: a comparison of safety and efficacy
Lewis RA; Katz GJ; Weiss MJ; Landry TA; Dickerson JE; James JE; Hua SY; Sullivan EK; Montgomery DB; Wells DT
Journal of Glaucoma 2007; 16: 98-103
